These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 12687601

  • 1. To the editor: Alcaligenes as a pathogen in airways chronic infection in cystic fibrosis.
    Romano L, Bellodi S, Lugani F, Manno G.
    Pediatr Pulmonol; 2003 May; 35(5):412-3. PubMed ID: 12687601
    [No Abstract] [Full Text] [Related]

  • 2. Alcaligenes infection in cystic fibrosis.
    Tan K, Conway SP, Brownlee KG, Etherington C, Peckham DG.
    Pediatr Pulmonol; 2002 Aug; 34(2):101-4. PubMed ID: 12112775
    [Abstract] [Full Text] [Related]

  • 3. [Etiopathogenic and therapeutic aspects of chronic respiratory infection in cystic fibrosis].
    Caramia G, Gagliardini R, Rocchi AL, Palumbo P.
    Minerva Pediatr; 1986 Jul 31; 38(13-14):569-78. PubMed ID: 3528799
    [No Abstract] [Full Text] [Related]

  • 4. Ultrastructural abnormalities in young patients with recurrent respiratory infections.
    Robertson B.
    Eur J Respir Dis; 1982 Nov 31; 63(6):496-7. PubMed ID: 6983455
    [No Abstract] [Full Text] [Related]

  • 5. [What is the burden of respiratory infection in the progression of cystic fibrosis].
    Bellon G.
    Rev Mal Respir; 2003 Apr 31; 20(2 Pt 2):S49-55. PubMed ID: 12910134
    [No Abstract] [Full Text] [Related]

  • 6. [Respiratory infection in cystic fibrosis: burden of illness in the progression of cystic fibrosis, previous deductions for the microbiological study of bronchial secretions and clinical criteria of infection].
    Thumerelle C.
    Rev Mal Respir; 2003 Apr 31; 20(2 Pt 2):S37-48. PubMed ID: 12910133
    [No Abstract] [Full Text] [Related]

  • 7. [Isolated pathogen microorganisms in respiratory samples from children with cystic fibrosis].
    Anzaudo MM, Busquets NP, Ronchi S, Mayoral C.
    Rev Argent Microbiol; 2005 Apr 31; 37(3):129-34. PubMed ID: 16323660
    [Abstract] [Full Text] [Related]

  • 8. Pulmonary infections in cystic fibrosis.
    Acta Paediatr Scand Suppl; 1982 Apr 31; 301():1-132. PubMed ID: 6963850
    [No Abstract] [Full Text] [Related]

  • 9. [Rhinosinusal pathology in chronic respiratory diseases in childhood a in mucoviscidosis].
    Romani U, Buffatti G, Mariotti M, Castellarin T.
    Minerva Otorinolaringol; 1969 Apr 31; 19(5):237-60. PubMed ID: 5380539
    [No Abstract] [Full Text] [Related]

  • 10. [Cystic fibrosis in adolescents].
    Dijkman JH, Kerrebijn KF, Bakker W.
    Ned Tijdschr Geneeskd; 1979 Jun 16; 123(24):1001-4. PubMed ID: 471083
    [No Abstract] [Full Text] [Related]

  • 11. [Infection and antibiotic therapy in respiratory manifestations of mucoviscidosis].
    Hennequet A.
    Ann Pediatr (Paris); 1968 Mar 02; 15(3):223-30. PubMed ID: 5744295
    [No Abstract] [Full Text] [Related]

  • 12. Some immunologic considerations of chronic pulmonary infection in cystic fibrosis.
    Gifford RR.
    J S C Med Assoc; 1972 May 02; 68(5):204-7. PubMed ID: 4554120
    [No Abstract] [Full Text] [Related]

  • 13. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN, Ratjen F.
    Semin Respir Crit Care Med; 2009 Oct 02; 30(5):587-95. PubMed ID: 19760546
    [Abstract] [Full Text] [Related]

  • 14. Clinical manifestations and treatment of pulmonary infections in cystic fibrosis.
    Burns JL, Ramsey BW, Smith AL.
    Adv Pediatr Infect Dis; 1993 Oct 02; 8():53-66. PubMed ID: 8217005
    [No Abstract] [Full Text] [Related]

  • 15. [Acute respiratory infections in patients with cystic fibrosis: role of viruses and mycoplasmas].
    Ojeda-Vargas M, Mateos M, Meseguer M, Baquero F.
    Enferm Infecc Microbiol Clin; 1990 Oct 02; 8(8):526. PubMed ID: 2095268
    [No Abstract] [Full Text] [Related]

  • 16. Therapeutic progress--review XVIII. Cystic fibrosis.
    Kohler JA, Rolles CJ.
    J Clin Hosp Pharm; 1986 Feb 02; 11(1):21-32. PubMed ID: 3514681
    [No Abstract] [Full Text] [Related]

  • 17. Carbenicillin in pulmonary infection complicating cystic fibrosis.
    Africa E, Rosenblum H.
    Del Med J; 1970 Nov 02; 42(11):307-8. PubMed ID: 5481955
    [No Abstract] [Full Text] [Related]

  • 18. Aztreonam: review of the clinical experience and potential uses in pediatrics.
    Lebel MH, McCracken GH.
    Pediatr Infect Dis J; 1988 May 02; 7(5):331-9. PubMed ID: 3288947
    [No Abstract] [Full Text] [Related]

  • 19. Atypical mycobacterial and fungal infections in cystic fibrosis.
    Whittaker LA, Teneback C.
    Semin Respir Crit Care Med; 2009 Oct 02; 30(5):539-46. PubMed ID: 19760541
    [Abstract] [Full Text] [Related]

  • 20. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR, Pressler T, Høiby N.
    J Cyst Fibros; 2008 Nov 02; 7(6):523-30. PubMed ID: 18693078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.